Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000191

Chairperson & CEO sold 9,500 shares at an average $580.43 ($5,514,046)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

12 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-17 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-11-17 Sale : show line 2 in the form 10b5-1 −373 $576.16 $214,909 333,570 I
2026-11-17 Sale : show line 3 in the form 10b5-1 −1,017 $577.14 $586,950 332,553 I
2026-11-17 Sale : show line 4 in the form 10b5-1 −1,763 $578.17 $1,019,319 330,790 I
2026-11-17 Sale : show line 5 in the form 10b5-1 −1,127 $579.11 $652,655 329,663 I
2026-11-17 Sale : show line 6 in the form 10b5-1 −955 $580.13 $554,026 328,708 I
2026-11-17 Sale : show line 7 in the form 10b5-1 −1,112 $581.18 $646,270 327,596 I
2026-11-17 Sale : show line 8 in the form 10b5-1 −449 $582.57 $261,576 327,147 I
Open-market sales · 9,500 sh · avg $580.43 · $5,514,046

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2026-11-17 Exercise or conversion : show line 13 in the form 10b5-1 Stock Option −9,500 $117.76 2027-03-15 9,500 5,410 I
Loading xslF345X06/primarydocument.xml…